MedtronicNeuro
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, MedtronicNeuro sits in the top decile of US sponsors by registered trial count (#372 of 15,742 sponsors by registered trial count).
MedtronicNeuro: 51 sponsored US clinical trials, 2 recruiting.
MedtronicNeuro sponsors 51 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 36 completed. 8 of these trials are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Chronic Pain, with 3 trials.
Top-decile sponsor footprint
MedtronicNeuro ranks in the top decile of sponsors by registered trial count (#372 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
36 of 48 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (75.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 2 |
| Phase 3 | 1 |
| Phase 4 | 7 |
Therapeutic Areas
Where MedtronicNeuro enrollment is open (later-stage tilt)
2 recruiting of 51 indexed (4% open); 36 completed (71%).
Phase mix: 8 late (III/IV) vs 3 early (I/II) (later-stage heavy).
Top condition: Chronic Pain (3 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
MedtronicNeuro: open-pipeline peers nationwide
Peers matched on 51 registered trials and 4% open enrollment, not the therapeutic-area sidebar.
MedtronicNeuro sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 51 trials (± recruiting share)
- Colgate Palmolive · 51 trials · 6% recruiting
- Ohio University · 51 trials · 10% recruiting
- Reproductive Medicine Associates of New Jersey · 51 trials · 14% recruiting
- Texas Woman's University · 51 trials · 6% recruiting
Sponsors near 4% open enrollment (± trial volume)
- Celgene · 4% recruiting · 308 trials
- U.S. Army Medical Research and Development Command · 4% recruiting · 77 trials
- Aldeyra Therapeutics · 4% recruiting · 26 trials
- DexCom · 4% recruiting · 26 trials
Related
What to do with this MedtronicNeuro page
51 registered trials is a research-attention snapshot, not an endorsement of MedtronicNeuro or any single study.
- 2 of MedtronicNeuro's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Chronic Pain is the condition MedtronicNeuro studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Chronic Pain trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. MedtronicNeuro pipeline card: 51 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.